REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
Regenxbio (RGNX) Misses Q1 EPS by 21c, Revenues Miss
May 7, 2020 5:36 PM EDTRegenxbio (NASDAQ: RGNX) reported Q1 EPS of ($1.08), $0.21 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $17.64 million versus the consensus estimate of $18.45 million.
"Our overall focus at REGENXBIO during the COVID-19... More
